Advances in Fasciola hepatica research using -omics technologies by Cwiklinski, Krystyna & Dalton, John
Advances in Fasciola hepatica research using -omics technologies
Cwiklinski, K., & Dalton, J. (2018). Advances in Fasciola hepatica research using -omics technologies.
International Journal for Parasitology. https://doi.org/10.1016/j.ijpara.2017.12.001
Published in:
International Journal for Parasitology
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2018 Elsevier.
This manuscript is distributed under a Creative Commons Attribution-NonCommercial-NoDerivs License
(https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the
author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:05. Apr. 2019
Advances in Fasciola hepatica research using –omics technologies 1	
 2	
 3	
Krystyna Cwiklinski1 and John P. Dalton1,2. 4	
 5	
 6	
1 – School of Biological Sciences, Medical Biology Centre, Queen’s University 7	
Belfast, Belfast, Northern Ireland, UK 8	
2 – Institute for Global Food Security (IGFS), Queen’s University Belfast, Belfast, 9	
Northern Ireland, UK 10	
 11	
Corresponding Author. k.cwiklinski@qub.ac.uk 12	
 13	
Keywords: Fasciola hepatica, helminth, trematode, genome, transcriptome, 14	
proteome.  15	
Abstract 16	
The liver fluke Fasciola hepatica is an economically important pathogen of livestock 17	
worldwide, as well as being an important neglected zoonosis.  Parasite control is 18	
reliant on the use of drugs, particularly triclabendazole (TCBZ), which is effective 19	
against multiple parasite stages.  However, the spread of parasites resistant to TCBZ 20	
has intensified the pursuit for novel control strategies.  Emerging –omic technologies 21	
are helping advance our understanding of liver fluke biology, specifically the 22	
molecules that act at the host-parasite interface and are central to infection, 23	
virulence and long-term survival within the definitive host.  This review discusses the 24	
sequencing technological advances that have facilitated the unbiased analysis of 25	
liver fluke biology, resulting in an extensive range of -omics datasets.  In addition, we 26	
highlight the –omics studies of host responses to F. hepatica infection, that, when 27	
combined with the parasite datasets, provide the opportunity for integrated analyses 28	
of host-parasite interactions.  These extensive datasets will form the foundation for 29	
future in-depth analysis of F. hepatica biology and development and the search for 30	
new drug or vaccine interventions. 31	
 32	
1. Introduction 33	
DNA sequencing technologies have rapidly evolved over the past few 34	
decades, stemming from the traditional Sanger methodology used to map the first 35	
human genome (Lander et al., 2001; Venter et al., 2001) to the recent high-36	
throughput sequencing technologies such as Roche 454 and Illumina (Reuter et al., 37	
2015) that we use today.  More recently, single cell sequencing has emerged, 38	
pioneered by Pacific Biosciences and Oxford Nanopore Technologies, through the 39	
PacBio and MinION platforms, respectively (Reuter et al., 2015).  As the technology 40	
for sequencing DNA has progressed, so too have the routine protocols for the 41	
extraction of nucleic acids and library preparation (Price et al., 2009); this has 42	
allowed sequencing projects to be carried out on even the most challenging species 43	
to propagate in the laboratory and those for which it was previously difficult to obtain 44	
adequate quantities of nucleic acids.  Consequently, the number of sequencing 45	
projects undertaken has exploded, including recent ambitious proposals to sequence 46	
10000 vertebrate genomes (Genome 10K project; Koepfli et al., 2015), 5000 47	
arthropods (i5K project; Poelchau et al., 2015) and all 10500 species of birds (B10K 48	
project; Jarvis, 2016), to name but a few.   49	
In the area of parasitology, a similar large-scale collaboration was initiated 50	
with the aim of sequencing 50 helminth genomes from human and veterinary 51	
parasites of global importance (50 Helminth Genomes Project, 50HGP; 52	
http://www.sanger.ac.uk/science/collaboration/50hgp).  The advances in sequencing 53	
technologies enabled the number of genomes sequenced under this directive to be 54	
exceeded.  Now in its ninth release, the database housing these genomes, 55	
WormBase ParaSite, comprises 134 genomes, representing 114 species (Howe et 56	
al., 2017).  In addition to acting as a central repository and publically-accessible 57	
database for the wider research community, WormBase ParaSite integrates all 58	
available genomic and transcriptomic data to provide functional annotation and 59	
expression information for each species and thus facilitate comparative genomics 60	
analysis.   61	
How we profile the repertoire of transcripts expressed by an organism, at a 62	
particular time-point or in response to external cues, has also evolved with advances 63	
in sequencing technology.  Studies first focused on analysing partial sequences, 64	
known as expressed sequence tags (ESTs) derived from libraries of cDNA clones 65	
(Parkinson and Blaxter, 2009).  In conjunction, serial analysis of gene expression 66	
(SAGE) methodology facilitated differential or temporal gene expression studies, as 67	
well as the detection and analysis of low abundant transcripts (Sun et al., 2004).  68	
However, it was the development of gene expression microarrays that initially 69	
instigated high throughput transcriptome analyses that are still used today (Schena 70	
et al., 1995; Malone and Oliver, 2011).  Since microarrays only detect known gene 71	
transcripts immobilised on microchips they are less useful for gene discovery.  By 72	
contrast, the emergence of RNA sequencing (RNAseq) allowed the analysis of all 73	
gene transcripts present within a given sample and now, advanced through the 74	
development of next-generation sequencing (NGS) technologies, has largely 75	
replaced microarrays for gene transcription analysis. 76	
This emerging array of transcriptome profiling tools has been applied 77	
extensively to helminth parasites.  Approximately 508,000 ESTs have been 78	
generated from Platyhelminth parasites and are housed in the NCBI database 79	
dbEST (dbEST release 130101; https://www.ncbi.nlm.nih.gov/dbEST/).  SAGE 80	
methodology has also been employed for the analysis of gene expression across 81	
different lifecycle stages (Knox and Skuce, 2005; Williams et al., 2007; Taft et al., 82	
2009).  More recently, large scale RNAseq analyses have been completed for a 83	
range of Platyhelminth parasites, several of which have been disseminated through 84	
the site Helminth.net (Martin et al., 2015).  These freely-accessible datasets have 85	
complemented ongoing genome projects.  86	
In parallel with techniques to analyse nucleic acids, advances in modern 87	
proteomic technologies have allowed the high throughput identification and 88	
characterization of complex proteins preparations (Yarmush and Jayaraman, 2002; 89	
Brewis and Brennan, 2010).  Progress has also been made in developing extraction 90	
protocols for soluble and membrane-bound proteins, as well increasing the 91	
sensitivity of proteomic technologies, including gel-free protocols that can be carried 92	
out on very small amounts of proteins (micrograms) (Scherp et al., 2011; Nature 93	
Method of the year 2012. 2013).  By integrating proteomic data with 94	
genomic/transcriptomic data functional annotation is more precise and can provide 95	
qualitative and quantitative information regarding the expression of genes and their 96	
products, as well as data such as the existence of splice variants or the nature of 97	
post-translational modifications. 98	
Parasite-host interaction is a complex phenomenon involving molecules 99	
produced by both partners.  The ability of helminth parasites to invade, migrate and 100	
survive within their hosts is expedited by the range of proteins they secrete/excrete.  101	
The roles these released proteins play during infection have been investigated in 102	
many studies using proteomic tools and have provided a rich source of 103	
immunomodulators, diagnostic reagents and vaccine candidates that can be cherry-104	
picked at will to bring forward into commercialisable biotherapeutics.  The available 105	
genomic/transcriptomic data, including those present in WormBase ParaSite, 106	
complement these proteomic studies, providing publically-available databases that 107	
can be used during the identification/annotation process to further our understanding 108	
of helminth parasites and their interaction with their hosts. 109	
In this review, we focus on the datasets available for the liver fluke parasite, 110	
Fasciola hepatica, and in particular how they are currently analysed and interrogated 111	
to enhance our knowledge of liver fluke biology with a particular emphasis towards 112	
elucidating how these parasites invade and survive within their hosts.  The lifecycle 113	
of this digenean trematode includes a snail intermediate host, within which the 114	
parasite undergoes a clonal expansion, and a mammalian definitive host, where the 115	
parasite develops into sexually mature adults, releasing 20000–24000 eggs per fluke 116	
per day (Boray, 1969).  Infection of the mammalian host occurs following the 117	
ingestion of the infective encysted stage, the metacercariae.  Within the intestine, the 118	
parasite excysts, as newly excysted juveniles (NEJ) that migrate across the intestinal 119	
wall, across the peritoneal cavity to the liver and bile ducts.  F. hepatica is known to 120	
infect a broad range of mammalian hosts, including rodents, ruminants, ungulates, 121	
kangaroos and primates (Robinson and Dalton, 2009), implying the parasite has 122	
evolved a universal process(s) of infection.  As a hermaphroditic parasite, F. 123	
hepatica has the ability to self- and cross-fertilise.  In addition, studies have shown 124	
that hybridisation with the sister species, Fasciola gigantica can occur, resulting in 125	
intermediate or hybrid forms as determined by analysis of mitochondrial genes and 126	
intergenic genome sequences (Le et al., 2008; Itagaki et al., 2011; Ichikawa-Seki et 127	
al., 2017).  128	
The extensive collection of -omics datasets now available for F. hepatica 129	
includes the draft genome, stage-specific transcriptomes, and proteomic datasets for 130	
the somatic proteome, secretome, extracellular vesicles and glycoproteome of the 131	
outer tegumental surface.  These datasets can now be used to investigate the 132	
complex features of the Fasciola lifecycle, particularly their effects on life history 133	
traits that directly impact on gene flow within liver fluke populations, influencing the 134	
spread of drug resistance and virulence/pathogenicity traits.   135	
 136	
2. Genomics 137	
2.1 The F. hepatica mitochondrial genome 138	
The characterisation and differentiation of various Fasciola species using 139	
morphological features is often unreliable and can only be used for the differentiation 140	
of adult parasites found within the bile ducts.  Molecular identification based on 141	
nuclear ribosomal and mitochondrial genes is a more robust method of species 142	
classification.  These molecular tools also provide markers for population genetic 143	
studies and epidemiological analysis of Fasciola spp.  The complete F. hepatica 144	
mitochondrial (mt) genome was the first to be sequenced from a trematode species 145	
(Le et al., 2001) and has since been used for several population genetics studies of 146	
F. hepatica (Walker et al., 2007; Walker et al., 2011; Walker et al., 2012; Bargues et 147	
al., 2017).  Similarly, the complete mt genome from F. gigantica has been reported 148	
(Liu et al., 2014), which now provides species-specific references that can be used in 149	
species characterization studies.  For example, Liu and colleagues (2014) 150	
sequenced the complete mt genome from an intermediate form of F. hepatica and F. 151	
gigantica found in the Heilongjiang province, China (Peng et al., 2009).  Based on 152	
intergenic spacer regions (ITS-1 & ITS-2) this isolate is indeed inferred to be a hybrid 153	
between F. hepatica and F. gigantica, although comparative analysis between 154	
Fasciola spp. mt genomes revealed that the intermediate form was more closely 155	
related to F. gigantica than to F. hepatica.  This study shows that hybridisation is not 156	
uniform across the genome and that sequence variations at different sites can occur, 157	
in this case within the nuclear ribosomal genes and the maternally inherited 158	
mitochondrial genes.  Thus, the study also highlighted the complexity incurred during 159	
hybridization of Fasciola species and challenges that their subsequent 160	
characterization presents.  161	
 162	
2.2 Nuclear genome 163	
To date 33 Platyhelminthes genomes are publically available within 164	
WormBase ParaSite, comprising species from the Trematoda, Cestoda, Monogenea 165	
and Rhabditophora Classes.  Analysis of the genome assembly sizes shows that 166	
although individual species vary in respect to their genome size, trends can be 167	
observed.  In general, the cestode tapeworms have considerably smaller genomes 168	
compared the other members of the Phylum Platyhelminthes.  The major exception 169	
to this statement is Spirometra erinaceieuropaei, which has one of the largest 170	
Platyhelminth genomes (1.3 Gb; Bennett et al., 2014).  Concerning the Class 171	
Trematoda, the blood flukes of the species Schistosoma have smaller genomes 172	
compared with other members of the Class.   173	
Surprisingly, F. hepatica has the largest trematode genome sequenced to 174	
date (1.3 Gb; Cwiklinski et al., 2015a).  For a parasite such as Fasciola that ensures 175	
its own species survival through the daily generation of large numbers of eggs, the 176	
evolution of a large genome appears counter-intuitive as it potentially imposes a cost 177	
on egg production.  The reason for the large genome size has yet to be determined, 178	
but our studies indicate that it has not arisen through genome duplication or an 179	
increase in the percentage of the genome that is comprised of repeat regions.  180	
Although an equivalent number of genes have been identified across the trematode 181	
genomes, comparative analysis reveals that increases in genome size are reflective 182	
of increases in average exon and intron length, though this alone does not fully 183	
explain the increased genome size of the F. hepatica genome.  Further analysis of 184	
the non-coding regions is required to determine their function and, in particular, their 185	
importance in gene regulation (ENCODE Project Consortium 2012). 186	
The recent genome sequencing of F. hepatica isolates from the Americas by 187	
McNulty and colleagues, confirmed that the large genome size is comparable 188	
between fluke isolates (McNulty et al., 2017).  Interestingly, the analysis of these 189	
American isolates revealed the presence of a Neorickettsia endobacterium within the 190	
parasite, which was further demonstrated by immunolocalisation studies that found 191	
the bacterium within the eggs, reproductive system and the oral suckers of adult 192	
fluke.  Consistent with other studies of trematode-Neorickettsia interactions, 193	
Neorickettsia could also be detected in the Fasciola eggs by PCR methods.  To date 194	
no other liver fluke isolates from other geographical locations have reported the 195	
presence of any Neorickettsia endobacteria, indicating that the acquisition of this 196	
endobacteria may have occurred since the introduction of F. hepatica to the 197	
Americas.  The study by McNulty and colleagues (2017) highlights the potential 198	
interaction between Fasciola and endosymbionts/endobacteria and warrants further 199	
investigation.  200	
Single nucleotide polymorphism (SNP) analysis of UK F. hepatica isolates, 201	
including isolates resistant to the frontline anthelminthic, triclabendazole 202	
(Hodgkinson et al., 2013) has revealed high levels of sequence polymorphism in the 203	
F. hepatica genome (Cwiklinski et al., 2015a).  In particular, a marked over-204	
representation of genes with high levels of non-synonymous polymorphism was 205	
associated with axonogenesis and chemotaxis, reflecting the changing environments 206	
the parasite encounters during its migration in the host.  This data has recently been 207	
complemented by microsatellite analysis that revealed high levels of genetic diversity 208	
and gene flow within field isolates in the UK (Beesley et al., 2017).  High levels of 209	
genetic diversity and gene flow may be important to counter the decline of allele 210	
diversity as a result of self-fertilisation (Noel et al., 2017). 211	
The current F. hepatica genome assembly (PRJEB6687; Cwiklinski et al., 212	
2015a) is comprised of a large number of scaffolds and contigs (20,158 scaffolds 213	
and 195,709 contigs, with a scaffold N50 of 204kb), mainly due to the size of the 214	
genome and the high percentage of repeat regions, which has hindered the 215	
assembly.  In the future, utilising sequencing platforms that generate longer reads as 216	
well as technologies such as optical mapping should resolve this problem.  The 217	
sequencing reads can then be mapped to the ten F. hepatica chromosomes 218	
(Sanderson, 1953), allowing analysis of genome structure and genomic comparison 219	
of Platyhelminth genome organisation. 220	
 221	
3. Transcriptomics 222	
The development of novel control strategies, vaccine and diagnostics aimed 223	
at specific F. hepatica lifecycle stages, requires an understanding of the genes that 224	
are transcribed at each time-point in development as well as their specific 225	
transcriptional abundance.  Initial studies of gene identification and analysis were 226	
based on a limited number of unannotated expressed sequence tags (ESTs; 6819 227	
sequences) generated from adult F. hepatica parasites by the Wellcome Trust 228	
Sanger Institute (ftp://ftp.sanger.ac.uk/pub/pathogens/Fasciola/hepatica/ESTs/).  229	
This EST database was also an essential resource for blasting peptide sequences 230	
for F. hepatica proteomic studies (Chemale et al., 2006; Robinson et al., 2009; 231	
Chemale et al., 2010; Hacariz et al., 2014; Morphew et al., 2014).   232	
The formative analysis of these EST sequences identified several key 233	
molecules of interest for further characterisation, including glutathione transferases 234	
(GSTs; Chemale et al., 2006), calcium binding proteins (Banford et al., 2013), mucin-235	
like proteins (Cancela et al., 2015) and the helminth defence molecule (Robinson et 236	
al., 2011; Martinez-Sernandez et al., 2014).  Enhancing our understanding of the F. 237	
hepatica lifecycle, Robinson and colleagues (2009) utilised an integrated 238	
transcriptomic and proteomic approach based on these adult-specific Fasciola ESTs, 239	
to profile the expression of proteins secreted by Fasciola parasites as they migrate 240	
through the host.  However, this analysis was based on the premise that similarities 241	
could be drawn between the proteins expressed by the adult parasites residing in the 242	
bile ducts and those expressed by the migrating NEJ parasites.  Utilising an adult-243	
specific database, especially one with a limited number of sequences, likely resulted 244	
in NEJ-specific proteins being overlooked. 245	
In 2010, Cancela and colleagues (2010) reported the generation of 1684 246	
ESTs from the excysted NEJ.  The limited number of ESTs is reflective of the 247	
amount of total RNA that could be extracted from 1200 NEJ and subsequently used 248	
for cDNA synthesis (200ng).  Nevertheless, analysis of these sequences identified 249	
several sequences that had not been previously reported within the adult ESTs, 250	
implying that they were NEJ-specific.  Specifically, several cathepsin cysteine 251	
proteases and antioxidant enzymes were characterised and showed that F. hepatica 252	
has adapted stage-specific proteases and enzymes to utilise throughout its lifecycle.  253	
The identification of novel stage-specific genes within this study highlighted the need 254	
for more extensive lifecycle stage-specific transcriptomes to further Fasciola 255	
research. 256	
Led by the developments in sequencing technologies, Young and colleagues 257	
(2010) reported the first extensive adult F. hepatica transcriptome sequenced using 258	
454 sequencing technology.  In comparison to the 6819-unannotated adult-specific 259	
EST sequences available, this study generated a total of 590, 927 high quality reads 260	
that were clustered into approximately 48,000 sequences, of which 15,423 261	
supercontigs of 745 bp (+ 517bp) were enriched for open reading frames (ORF).  262	
These sequences were subjected to extensive homology searches and protein 263	
prediction, using tools such as InterProScan, gene ontology (GO) and KOBAS 264	
(KEGG Orthology-Based Annotation System) to annotate the predicted proteins.  265	
Based on the publically available datasets at the time, approximately 44% of the 266	
sequences were classified, identifying proteins representative of the adult stage 267	
parasite.  In keeping with the fact that F. hepatica expresses a range of cathepsin 268	
cysteine proteases, several cysteine peptidase family members were identified within 269	
the adult transcriptome.  The predicted protein sequences were also screened for 270	
signal peptide and transmembrane domains to profile those proteins secreted by 271	
classical pathways within the ES proteins by the adult parasites; this analysis 272	
identified all the 160 ES proteins reported by Robinson et al. (2009).  Importantly, 273	
comparing the Robinson et al. (2009) proteomic dataset with this more extensive 274	
adult F. hepatica database resulted in the annotation of previously unclassified 275	
proteins, including a group of fatty acid binding proteins and redox antioxidant 276	
enzymes.  A further 18,347 contigs have been generated using 454 sequencing of 277	
adult fluke cDNA by Wilson et al. (2011) during their interrogation of the adult 278	
tegument.  This more extensive dataset for adult F. hepatica has been interrogated 279	
by various research groups and has led to the identification of a range of proteins 280	
including, SCP/TAPS proteins (Cantacessi et al., 2012), glutathione transferases 281	
(Morphew et al., 2012) and cathepsin cysteine proteases (Morphew et al., 2011).   282	
The available transcriptome data and subsequent analysis for Fasciola spp. 283	
has since been further improved with the development of short read Illumina 284	
sequencing that has increased sequence depth and coverage (Reuter et al., 2015).  285	
Investigation of the similarities between F. hepatica and F. gigantica, particularly 286	
those molecules important at the host-parasite interface, has been carried out 287	
following the first characterisation of the F. gigantica adult transcriptome (Young et 288	
al., 2011).  Similarly, in depth Illumina sequencing has been applied to the study of 289	
virulence and immunomodulation-related genes of adult F. hepatica, identifying 62 290	
previously uncharacterised virulence-related genes.  In silico characterisation, 291	
subsequently implied that these genes have immunomodulatory properties since 292	
they were comparable to various immune related molecules, including cytokines and 293	
immune receptors (Hacariz et al., 2015).   294	
In particular, the development of Illumina sequencing technology has 295	
advanced our knowledge of other F. hepatica lifecycle stages that have been 296	
previously difficult to analyse.  We have reported the sequencing of several early 297	
lifecycle stages, namely the infective metacercariae stage, the NEJ parasites 1hr, 298	
3hr and 24hr post-excystment, as well as juvenile parasites at 21-day post infection 299	
and adult parasites which has provided a transcriptional profile of F. hepatica during 300	
infection (Cwiklinski et al., 2015a).  Differential gene transcription analysis showed 301	
that the parasite regulates the transcription of many of its genes with progressively 302	
more genes being highly transcribed as the parasite rapidly grows and develops in 303	
preparation for migration through the host liver (>8000; Cwiklinski et al., 2015a).   304	
The integration of transcriptome data with the F. hepatica genome has also 305	
revealed that gene family expansion is a key feature of F. hepatica adaptation and 306	
survival; we have shown that F. hepatica transcribes different members of these 307	
gene families during different stages of the lifecycle (Cwiklinski et al., 2015a).  Key 308	
examples of such expanded gene families are the cathepsin cysteine proteases and 309	
the microtubule-related alpha and beta tubulins genes.  Biochemical analysis of the 310	
family of cathepsin proteases has shown that the different clades have evolved 311	
distinctive peptidolytic activity specific to the requirements of different lifecycle stages 312	
(Robinson et al., 2008).  Similarly, the transcription of the diverse range of beta 313	
tubulin isotypes that are temporally regulated could explain the stage-specific 314	
efficacy of benzimidazole anthelminthics (Sanabria et al., 2013).  315	
Coupled with comprehensive proteomic analyses, a current focus of our work 316	
is to investigate the infective and invasive lifecycle stages, namely the metacercariae 317	
and NEJ to elucidate how the parasite prepares for infection and undergoes 318	
alterations to ensure its own survival (Cwiklinski and Dalton, unpublished).  In depth 319	
interrogation of the transcriptome data available for these lifecycle stages has shown 320	
that the infective stage, metacercariae, is metabolically active and that early juvenile 321	
stages regulate the transcription of metabolic pathways, particularly those related to 322	
aerobic energy metabolism (Cwiklinski and Dalton, unpublished).   323	
McNulty et al. (2017) reported a transcriptome analysis of F. hepatica eggs, 324	
metacercariae and adult stages, as part of their genome characterisation of 325	
American F. hepatica isolates, and identified several gene sets that were 326	
overexpressed by specific lifecycle stages.  In particular, consistent with our analysis 327	
(Cwiklinski et al., 2015a), the cathepsin proteases were found to be highly regulated; 328	
different clade isotypes were over-expressed by the metacercariae compared with 329	
the adult parasite.  The most significantly over-expressed gene in eggs was found to 330	
be the rate-limiting enzyme of the pentose phosphate pathway, glucose-6-phosphate 331	
dehydrogenase.   332	
Recently, there has been an interest in extracellular vesicles within parasite 333	
secretomes and the role they play at the host-parasite interface (Marcilla et al., 2014; 334	
Coakley et al., 2015).  Extracellular vesicles (EVs) enable cell-to-cell communication 335	
by transferring proteins, lipids and microRNA (El Andaloussi et al., 2013; Record et 336	
al., 2014; Huang-Doran et al., 2017).  At least two sub-populations of EVs with 337	
different protein content have been shown by centrifugation methods to be secreted 338	
by F. hepatica, including large EVs released from the parasite gut (15K EVs) and 339	
smaller exosome-like vesicle released from the tegumental surface (120K EVs) 340	
(Marcilla et al., 2012; Cwiklinski et al., 2015b).  Transcriptomic analysis of the genes 341	
involved in the EV biogenesis pathway suggests that the synthesis of these two sub-342	
populations of EVs occur via separate pathways, namely ESCRT and lipid-343	
related/ESCRT-independent pathways, respectively (Cwiklinski et al., 2015b; de la 344	
Torre-Escudero et al., 2016).    345	
Further analyses of Fasciola microRNAs (miRNAs) has been carried following 346	
the generation of three small RNAseq libraries from adult parasites (Xu et al., 2012; 347	
Fromm et al., 2015), the NEJ (Fontenla et al., 2015) and extracellular vesicles 348	
isolated from adult parasite secretion (Fromm et al., 2015).  These studies have 349	
identified 52 non-coding microRNAs (miRNAs) corresponding to 32 metazoan-350	
conserved miRNA families (Fromm et al., 2017).  In addition, five F. hepatica-specific 351	
sequences were identified.  Comparative analysis with F. gigantica indicates that 352	
these five sequences are specific to F. hepatica and are not shared across the 353	
Fasciola genus.  Correspondingly, eight miRNAs have been identified as F. 354	
gigantica-specific (Xu et al., 2012).  Whether or not these Fasciola-specific miRNAs 355	
are important for infection of the mammalian host has yet to be determined.  356	
Throughout the lifecycle the abundance of the miRNAs expressed by F. hepatica 357	
varies, indicating stage-specific roles (Fromm et al., 2017), with those miRNAs 358	
present within the extracellular vesicles most likely important for host-parasite 359	
interactions.  In particular, the predicted targets of five immuno-regulatory miRNAs 360	
found to be enriched within the EV warrant further investigation (Fromm et al., 2015; 361	
Fromm et al., 2017). 362	
 363	
4. Proteomics 364	
Molecules that are secreted/excreted from liver flukes, also known as the ES 365	
proteins, are considered necessary for their migration through the tissues of the host 366	
and evasion from immune responses.  While the early migrating stages of F. 367	
hepatica are mainly tissue feeders, adult parasites residing in the bile ducts are 368	
obligate blood feeders.  The adult flukes are readily recovered from the bile ducts of 369	
infected livestock and ES proteins are released in abundance when the adult 370	
parasites are maintained in culture medium (even microgram quantities can obtained 371	
from 10 adult parasites in vitro).  Thus, the ES proteins of adult parasites have been 372	
extensively studied using proteomic tools.  Early studies of F. hepatica proteins used 373	
radio-metabolic labelling to differentiate between the proteins of the various lifecycle 374	
stages (Irving and Howell, 1982; Dalton et al., 1985).  Isoelectric focusing and 375	
densitometry were also carried out to characterise the ES proteins secreted by flukes 376	
maintained in different mammalian systems, namely llamas, rats, mice and cattle, 377	
which showed a different banding pattern (Lee et al., 1992a; Lee et al., 1992b).  378	
Jefferies and colleagues (2000; 2001) improved this analysis using two-dimensional 379	
gel electrophoresis and subsequent characterisation and annotation of protein spots 380	
to identify a range of cathepsin L proteases, superoxide dismutase, peroxiredoxin, 381	
glutathione S-transferases and fatty acid binding proteins.  This study formed the 382	
basis for further in-depth analyses of these protein families using modern proteomic 383	
techniques and phylogenetic tools to elucidate how these protein families have 384	
diverged and adapted (Chemale et al., 2006; Robinson et al., 2008; Marcilla et al., 385	
2008; Morphew et al., 2011; Morphew et al., 2012; Morphew et al., 2013; Cwiklinski 386	
et al., 2015b; Morphew et al., 2016; Di Maggio et al., 2016).  Furthermore, proteomic 387	
analysis of the proteins within the extracellular vesicles released within the 388	
secreted/excreted proteins has revealed that the 15K and 120K sub-populations of 389	
EVs released by F. hepatica vary in their protein cargo composition (Cwiklinski et al., 390	
2015b). 391	
Analysis of the adult liver fluke secretome has been used to assess the mode 392	
of action of the anthelminthic drug triclabendazole (TCBZ), and suggest that TCBZ 393	
broadly effects liver fluke metabolism (Chemale et al., 2010).  In particular, protein 394	
signatures of liver fluke parasites susceptible and putatively-resistant to TCBZ can 395	
be discerned based on the parasite’s response to the TCBZ metabolite 396	
triclabendazole sulphoxide (TCBZ-SO) (Morphew et al., 2014).  Parasite 397	
susceptibility to TCBZ characterised by lethal activity was indicated by the presence 398	
of actin, gelsolin, DJ-1 and triose phosphate isomerise, whereas putative resistance 399	
characterised by sub-lethal activity was indicated by the presence of calreticulin, 400	
cathepsin L proteases and enolase.  These highly-specific protein profiles provide 401	
potential markers that can be used for future TCBZ efficacy studies. 402	
In contrast to the large amount of protein secreted by the adult parasites, 403	
analysis of the early developmental and migratory stages of F. hepatica is more 404	
challenging given their small size and difficulty in locating them in hosts tissues.  405	
Accordingly, fewer proteomic studies have been reported for these stages.  The 406	
molecular investigation of egg embryonation, however, characterised 28 proteins 407	
within the somatic proteome from 200,000 eggs (Moxon et al., 2010), and revealed 408	
that protein complexity increases as eggs mature, consistent with the development 409	
of the miracidia stage.  This study also demonstrated that eggs have a substantially 410	
different protein profile to the other developmental stages of F. hepatica (Moxon et 411	
al., 2010).  Similarly, a study of the secretome of an intra-molluscan stage, in vitro 412	
transformed mother sporocysts, required 388,000 parasites to generate sufficient 413	
protein for analysis (Gourbal et al., 2008).  Seventeen of the most abundant proteins 414	
were analysed, in particular two antioxidant enzymes, Cu/Zn superoxide dismutase 415	
and thioredoxin (Gourbal et al., 2008).  These enzymes were previously reported 416	
within the adult secretome (Jefferies et al., 2001; Robinson et al., 2009), suggesting 417	
a uniform process of detoxification of reactive oxygen species. 418	
The development of proteomic tools and the accessibility of F. hepatica 419	
parasites have facilitated the expansion of the available proteome datasets for the 420	
NEJ migratory stages.  Profiling the proteins secreted by the early infective stages, 421	
namely the NEJ 24hr post-excystment and juvenile fluke 21 days post-infection with 422	
those of adult parasites has allowed stage-specific proteins to be determined 423	
(Robinson et al., 2009).  A greater level of protein complexity was observed within 424	
the juvenile secretome (45 proteins), compared with the NEJ 24hr (29 proteins) and 425	
adult secretome (22 proteins), with a wider range of cathepsin isotypes and 426	
antioxidant enzymes being secreted.  This is consistent with the migratory and 427	
feeding traits of this stage, and the upregulation of gene transcription observed 428	
during this stage (Andrews, 1999; Cwiklinski et al., 2015a).  The NEJ 24hr 429	
secretome profile also confirmed the initial characterisation by N-terminal 430	
sequencing of the NEJ secreted proteins carried out in the Meeusen laboratory 431	
(Tkalcevic et al., 1995), which described an abundance of cathepsin L and 432	
asparaginyl endopeptidase cysteine proteases. 433	
Facilitated by the sequencing of the F. hepatica genome, Di Maggio and 434	
colleagues (2016) recently reported a comprehensive analysis of the secreted 435	
proteins of adult liver fluke and NEJ 48hr post-excystment and compared these with 436	
the somatic proteome of the NEJ 48hr.  Using gel free proteomic techniques, this 437	
study identified 202 proteins within the adult secretome, 90 proteins within the NEJ 438	
48hr secretome and 575 proteins in the somatic proteome of the NEJ 48hr.  439	
Consistent with other secretome analyses, a range of proteases and protease 440	
inhibitors were detected by both developmental stages, representing >70% and 441	
<10% of the total protein secreted, respectively.  Furthermore, previously unreported 442	
proteins were identified within the NEJ somatic proteome, including structural 443	
proteins and proteins related to metabolism, expanding our knowledge of this 444	
lifecycle stage.   445	
Untangling the complexities of host-parasite interactions is key to furthering 446	
our understanding of how this helminth evades the host immune system.  The adult 447	
liver fluke parasites reside within the bile ducts immersed in bile composed of bile 448	
acids, phospholipids, cholesterol, bilirubin and inorganic salts (Farina et al., 2009).  449	
Safe from the host’s immune response (Andrews, 1999; Correia et al., 2001), 450	
proteomic analysis has shown that the adult secretome in the bile of sheep infected 451	
with F. hepatica is dominated by cathepsin L proteases (Morphew et al., 2007) 452	
similar to that shown in vitro (Robinson et al., 2009; Morphew et al., 2011).  453	
Key to the survival within the mammalian host is the parasite tegument that 454	
can be rapidly turned over to prevent attachment of immune effector cells.  455	
Proteomic characterisation of the adult tegument was found to be enriched in 456	
structural proteins, transporters, proteins involved in secretory pathways and 457	
antioxidant enzymes (Wilson et al., 2011; Hacariz et al., 2012).  A similar range of 458	
proteins were also identified within the somatic proteome of the outer tegumental 459	
surface of NEJ (Hernandez-Gonzalez et al., 2010).  Furthermore, recent analysis 460	
has been carried out on the tegumental immunoprecipitate formed following the 461	
incubation of live adult F. hepatica flukes in purified IgG from F. gigantica-infected 462	
Thin Tailed sheep (Cameron et al., 2017).  This study identified several molecules 463	
consistent with previous analyses of the tegument (Wilson et al., 2011; Hacariz et al., 464	
2012), as well as a range of proteins associated with F. hepatica exosomes (15K 465	
EVs; Cwiklinski et al., 2015b).  In addition, it highlighted the cross-reactivity between 466	
antibodies elicited against F. gigantica during infection of Thin Tailed sheep and F. 467	
hepatica tegumental proteins, and raised the interesting question of whether different 468	
proteins and EV components are secreted/released under different ‘environmental’ 469	
situations.  470	
 471	
5. Glycomics 472	
To date F. hepatica glycomic analyses have focussed on the outer surface of 473	
the parasite, the glycocalyx, that is rich in glycoproteins and glycolipids (Threadgold, 474	
1976).  Analysis has shown that the tegumental surface is highly glycosylated, with 475	
an abundance of mannose-rich N-linked glycoproteins present on the surface, spines 476	
and suckers (Garcia-Campos et al., 2016; Ravida et al., 2016a; Ravida et al., 477	
2016b).  The exact role these N-glycoproteins play at the host-parasite interface is 478	
currently unknown, though parasite glyco-conjugates that been implicated in evading 479	
the host immune response (van Die and Cummings, 2010).  Moreover, blocking of 480	
the N-glycans on the surface on the NEJ using lectins has been shown to inhibit their 481	
migration across the intestinal wall (Garcia-Campos et al., 2017).  Studies of the F. 482	
hepatica glycans have shown that they have immune modulatory properties 483	
modulating toll-like receptor-induced maturation of dendritic cells through 484	
carbohydrate specific receptors (CLR) (Rodriguez et al., 2015; Ravida et al., 2016a; 485	
Rodriguez et al., 2017).  In contrast to the analysis of the F. hepatica N-glycans, the 486	
composition of the O-glycans has yet to be determined, though potential sites have 487	
been identified within the glycoproteins of the tegument (Ravida et al., 2016b).   488	
The glycocalyx is also rich in glycolipids that are highly antigenic (Wuhrer et 489	
al., 2003) and share terminal Galα1-4Gal and Galβ1-6Gal motifs with cestodes that 490	
result in serological cross-reactivity (Wuhrer et al., 2004).  As well as being cross-491	
reactive with other members of the Phylum Platyhelminthes, these glycolipids also 492	
mimic mammalian-type glycolipids (Wuhrer et al., 2001; Wuhrer et al., 2004), 493	
facilitating parasite survival.  494	
 495	
6. Proteomic and transcriptomic analysis of host responses to F. hepatica 496	
Several recent studies have utilised -omics approaches to investigate the 497	
responses of the host during infection with F. hepatica with the aim to elucidate host 498	
responses that mirror the stage of infection and the developmental changes that 499	
occur within the advancing parasite.  These large-scale investigations of the host 500	
responses give an unbiased global view of the effects of fasciolosis on host immune 501	
tissues, and have revealed novel aspects of pathogenesis associated with infection.  502	
In addition, these approaches are being used to evaluate potential vaccine 503	
candidates, identifying the genes involved in conferring protection (Wesołowska et 504	
al., 2013; Rojas-Caraballo et al., 2017). 505	
Transcriptomic responses within macroscopic lesions of F. hepatica-infected 506	
liver at 8 weeks post infection (wpi) in sheep revealed that gene expression is highly 507	
regulated (Alvarez Rojas et al., 2015), consistent with comparable microarray studies 508	
of mice (Rojas-Caraballo et al., 2015).  Several processes characteristic of acute 509	
fasciolosis and upregulated in response to the damage caused by the parasite were 510	
identified.  Genes corresponding to fibrosis and tissue repair were found to be 511	
upregulated, consistent with the subsequent tissue regeneration required following 512	
the invasive migration of the parasite.  In keeping with observations that helminth 513	
infections typically skew host immune responses towards a Th2 type, genes 514	
associated with Th2 differentiation and B cell activation were found to be 515	
upregulated, while Th1 type responses were down-regulated.  Interestingly, this 516	
study also reported that an increased abundance of circulating reticulocytes is 517	
associated with the blood feeding activity of F. hepatica, which can cause anaemia.  518	
Increased transcription of haemoglobin-related genes and four genes putatively 519	
associated with Fanconi anaemia were also observed. 520	
In other investigations of the host responses to fasciolosis, two recent studies 521	
analysed the transcriptomic responses of ovine peripheral blood mononuclear cells 522	
(PBMC) at stages throughout infection (Alvarez Rojas et al., 2016; Fu et al., 2016).  523	
Despite different protocols being used for sample preparation, RNA extraction and 524	
subsequent analysis of the RNAseq data, both studies reveal that gene transcription 525	
is highly regulated during F. hepatica infection of sheep, particularly during acute 526	
infection (1-2 wpi).  Both studies also observed the upregulation of genes associated 527	
with TGF beta signalling, including the genes TGF beta, collagen type 1 and the 528	
downstream SMAD signalling genes.  These genes play a major role in fibrosis, 529	
which were also observed in the transcriptome analysis of infected liver described 530	
above (Alvarez Rojas et al., 2015).  Upregulation of genes associated with the 531	
complement and coagulation cascades, chemokine signalling pathway and cytokine-532	
cytokine receptor interaction pathway were also reported by Alvarez Rojas et al. 533	
(2016).   534	
Consistent with the polarization of immune responses towards a Th2 type, the 535	
gene encoding inducible nitric oxide synthase (iNOS) was shown to be down-536	
regulated in response to infection with F. hepatica at both acute and chronic stages 537	
in the study by Fu et al. (2016).  Transcription of Th17 related genes were also 538	
down–regulated, suggesting that F. hepatica is able to inhibit the differentiation and 539	
stability of Th17 cells.  In contrast with the study by Fu and colleagues (2016), 540	
however, genes encoding interleukins, particularly those related to Th2 type 541	
responses, such as IL-4, were not reported by Alvarez Rojas et al. (2016) to be 542	
differentially expressed at statistical levels.  This difference may reflect the different 543	
protocols used to process the PBMCs for RNA extraction, namely processing fresh 544	
cells versus storage in RNAlater, which may have had an effect on the stability of 545	
gene expression profiles (Debey-Pascher et al., 2011; Eikmans et al., 2013).  546	
Equally, the type of strategy used for sequence analysis may contribute to the 547	
differences observed.  548	
As infection by F. hepatica progresses, the amount and composition of 549	
immune cells present both within the peritoneal cavity and circulating in the 550	
peripheral blood shifts to an abundance of eosinophils, which is associated with a 551	
polarisation to Th2 type immune responses.  Differential eosinophil cell counts were 552	
only reported in the Alvarez-Rojas et al. study (2016), and showed the infected 553	
animals had substantially more eosinophils than the control non-infected animals.  At 554	
4 wpi, the eosinophil count in the infected group ranged from 12-39% compared with 555	
the control group counts of 1-5%.  Therefore, the changes of transcriptomic 556	
response are reflective of both a change in transcription during infection as well as a 557	
change in the number and type of cells within the PBMC fraction and must be 558	
interpreted accordingly.   559	
Compared with inbred mouse strains, large animal mammalian hosts of 560	
helminth parasites, in particular sheep and cattle are genetically more variable, at 561	
both individual animal level and between breeds.  This can have a significant effect 562	
on how an animal or animal breed responds to infection with F. hepatica (Ardia et al., 563	
2011).  In the case of the two studies analysing transcriptomic responses in PBMC, 564	
each used different sheep breeds sorted into groups of four animals.  To address the 565	
possible between-animal variation Alvarez Rojas et al. (2016) employed two 566	
strategies to analyse their data; (1) assessment of each animal as an independent 567	
experiment and (2) treating each group (control non-infected and infected) as 568	
biological replicates.  Differentially expressed genes identified by both strategies 569	
were then used for further analysis, resulting in the identification of 183 and 76 570	
genes differentially expressed at 2 wpi and 8 wpi, respectively.  In comparison, the 571	
study by Fu et al. (2016), which compared animals as biological replicates, identified 572	
6490 differentially expressed genes at 1 wpi, indicating that many genes of interest 573	
were overlooked by the stringent process employed by Alvarez-Rojas et al. (2016).  574	
However, the sheep breed-specific responses may also be a factor in the differences 575	
observed between these trials.  Therefore, it is important for studies of host-parasite 576	
interactions in ruminants that sufficient numbers of animals are used and that the 577	
type of analysis utilised is appropriately considered and validated.  578	
The host responses to the migrating parasites within the peritoneal 579	
compartment during early infection and in the bile ducts consistent with chronic 580	
infection have also been investigated using proteomic tools.  Early fasciolosis is 581	
characterised by the migration of F. hepatica through the intestinal wall to the liver 582	
via the peritoneal cavity.  Proteomic analysis of the peritoneal fluid from sheep 583	
infected by F. hepatica at 18 days post infection (dpi) identified an abundance of 584	
proteins associated with the complement system and proteins associated with the 585	
liver extracellular matrix (ECM) (Ruiz-Campillo et al., 2017).  The presence of 586	
proteins associated with the liver ECM, including collagen VI, fibronectin and 587	
fibrocystin, is likely the result of the damage caused by the parasite as it invades and 588	
migrates through the liver.  Intriguingly, this study also detected two ECM-related 589	
molecules, periostin and vascular cell adhesion protein 1 (VCAM-1), that mediate 590	
leukocyte infiltration and are associated with marked eosinophilia, which warrant 591	
further investigation as biomarkers of infection. 592	
Systemic responses have been analysed using proteomic tools to identify 593	
biomarkers of infection within the serum.  Rioux et al. (2008) showed that there were 594	
significant changes within the sera beginning within 3 weeks of infection, consistent 595	
with the transcriptomic analysis of PBMCs that highlighted a greater level of 596	
differential gene expression during acute infection (Fu et al., 2016; Alvarez Rojas et 597	
al., 2016).  These striking changes also coincide with marked expression of >8000 598	
genes that accompany the rapid growth and development of F. hepatica in the first 599	
three weeks of infection (Cwiklinski et al., 2015a).  Two markers of particular interest, 600	
namely transferrin and apolipoprotein A-IV (Apo A-IV), were upregulated during this 601	
early period (Rioux et al., 2008).  Transferrin is associated with the anaemia caused 602	
by the blood feeding parasites, whereas Apo A-IV is associated with regulation of 603	
appetite within the intestine of mammals (although studies in rats and mice insinuate 604	
a possible role within the liver; VerHague et al., 2013).  In comparison, levels of 605	
transferrin detected within the bile by Morphew et al. (2007) were reduced compared 606	
with levels in the serum, further highlighting that the data can vary significantly 607	
depending of the sample type (serum, bile, peritoneal fluid etc) and time of infection.  608	
 609	
7. Concluding remarks 610	
Over the last few decades major advances that have been made through –611	
omics technologies have provided the liver fluke community with an extensive array 612	
of datasets that can be interrogated to further our understanding of liver fluke biology 613	
(Fig. 1).  The number of genes encoded within the F. hepatica genome has been 614	
clarified.  In particular, this information has been crucial in elucidating gene family 615	
organisations, which in the past have been complicated by the large number of gene 616	
sequences of similar classification present within the NCBI database.  In addition, 617	
the genes transcribed by F. hepatica have been found to be highly regulated 618	
throughout the lifecycle within the mammalian host.  This knowledge is vital for our 619	
continuing efforts to develop control strategies that, in particular, target the early 620	
stage parasites.  Proteomic analysis of the secreted/excreted proteins has 621	
highlighted key molecules that play an important role at the host-parasite interface.  622	
Biochemical characterization of these key molecules has also revealed stage-623	
specific adaptations, including the activity of cathepsin L proteases that includes 624	
collagenolytic activity specific to the juvenile parasites and haemolytic activity 625	
restricted to the adult parasites (Robinson et al., 2008).  It has also revealed some 626	
unexpected adaptations such as the kunitz-type serpin inhibitors that have inhibitory 627	
activity against cathepsin L cysteine proteases and not serine proteases (Smith et 628	
al., 2016).   629	
However, the function of a large proportion of F. hepatica genes and the 630	
proteins they encode still remain unknown.  In general, these genes only share 631	
homology with uncharacterised genes from other Platyhelminthes, indicating that 632	
they are Phylum-specific.  Further investigation is therefore required to decipher the 633	
function these genes play and specifically their importance for host-parasite 634	
interactions.  This can be achieved utilising post-genomic tools such as RNA 635	
interference (RNAi) and CRISPR, as well as protein structural analysis to increase 636	
our knowledge of these uncharacterised genes, facilitating the annotation of 637	
Platyhelminthes datasets.  Furthermore, the addition of this information into the 638	
various software packages available for omics analyses, such as STRING 639	
(Szklarczyk et al., 2015) and PANTHER (Mi et al., 2017) where there is a current 640	
lack of data relating to the Phylum Platyhelminthes, is essential to expand our 641	
knowledge of parasite protein-protein interaction networks.  642	
How parasites regulate their genes, specifically in response to their 643	
environment, particularly the host immune response, is becoming an area of intense 644	
interest.  In particular, this analysis has encompassed understanding the epigenetic 645	
process of gene regulation, through DNA methylation, histone modification and non-646	
coding RNA associated with gene silencing (Egger et al., 2004).  The role these 647	
epigenetic processes play to facilitate Fasciola invasion and survival has yet to be 648	
investigated.  However, studies of closely related Platyhelminthes have indicated 649	
that it warrants further investigation.  In particular, the study of DNA methylation 650	
across the Phylum Platyhelminthes has shown that cytosine methylation is a 651	
functionally conserved epigenetic feature (Geyer et al., 2013).  Furthermore, recent 652	
analysis of the epigenome of Schistosoma mansoni cercariae has revealed that 653	
histone modifications play an important role in regulating the transcription of genes, 654	
with the cercariae being transcriptional inactive (Roquis et al., 2015).  In-depth of 655	
analysis of the Fasciola genome has already revealed an array of non-coding small 656	
RNAs that may play a part in the post-transcriptional regulation of Fasciola genes 657	
and/or be important for the regulation and manipulation of the mammalian host.  658	
Similar analysis of the epigenome of the different lifecycle stages will show if there 659	
are any lifecycle stage-regulatory factors associated with liver fluke gene regulation.   660	
For the future development of control strategies, a greater understanding of 661	
host helminth interactions is paramount.  This review has discussed the large-scale 662	
datasets available for the study of liver fluke infection, from both the parasite and the 663	
mammalian host.  Going forward the analyses of these data should be integrated to 664	
elucidate the delicate interplay that occurs during infection and to determine if the 665	
pathogenicity/virulence of liver fluke isolates within field populations plays a role in 666	
this interaction.   667	
 668	
  669	
Figure Legend 670	
Fig. 1. Schematic of the major Fasciola –omics advances detailed over time. The 671	
principal references are denoted by numbers as follows: 1) Dalton et al., 1985; 2) 672	
Tkalcevic et al., 1995; 3) Jefferies et al., 2000; 4) Le et al., 2001; 5) 673	
ftp://ftp.sanger.ac.uk/pub/pathogens/Fasciola/hepatica/ESTs/; 6) Gourbal et al., 674	
2008; 7) Robinson et al., 2009; 8) Young et al., 2010; 9) Cancela et al., 2010; 10) 675	
Moxon et al., 2010; 11) Xu et al., 2012; 12) Marcilla et al., 2012; 13) Cwiklinski et al., 676	
2015a; 14) McNulty et al., 2017; 15) Garcia-Campos et al., 2016; 16) Ravida et al., 677	
2016b; 17) Di Maggio et al., 2016. 678	
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